AliveCor has launched its third generation AliveCor Heart Monitor. AliveCor says that the third generation device is 50% thinner and 40% lighter and was designed from first-hand customer feedback and in collaboration with global design firm IDEO.
In the first two months since the atrial fibrillation (AF) detector algorithm was launched, AliveCor has detected more than 20,000 incidents of AF in more than 30% of users recording ECGs. Detecting AF is the first step to initiating a treatment plan to reduce stroke risk, as people with AF are five times more likely to suffer a stroke than those without the condition.
“The AliveCor Heart Monitor leads to results that I can use to manage my patients remotely,” says Jeffrey Olgin, chief, division of cardiology co-director, Heart and Vascular Center at the University of California, San Francisco, USA. “Seeing my patients’ electrocardiogram results in real-time is the next best thing to having them in my office when the event takes place.”
“Big data and personalised medicine are revolutionising the delivery of care and have the potential to disrupt the way we think about healthcare,” says Euan Thomson, president and chief executive officer at AliveCor.
